1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
Fabry Disease - Epidemiology Forecast - 2032

Fabry Disease - Epidemiology Forecast - 2032

  • May 2022
  • 90 pages
  • ID: 6276121
  • Format: PDF
  • Delve Insight

Summary

Table of Contents

‘Fabry Disease—Epidemiology Forecast—2032’ report delivers an in-depth understanding of the historical and forecasted epidemiology of Fabry Disease in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Fabry Disease: Disease Understanding

Fabry Disease Overview
Fabry disease is an inherited lysosomal storage disease caused by a nonfunctional or only partially functional enzyme, alpha-galactosidase A (?-gal A). Decreased activity of alpha-gal A in lysosomes results in the accumulation of enzyme substrates (Gb3 and lyso-Gb3) which cause cellular damage in tissues throughout the body.
Symptoms include pain that spreads through the body (a Fabry crisis), gastrointestinal complications, headaches, impaired sweating, vertigo, and hearing impairment.
It was once thought that Fabry disease only affected males. Females were considered only “carriers”; however, now it is known that both men and women can get Fabry disease, although it may manifest differently depending on gender. Despite being X-linked, heterozygous women may experience all the signs and symptoms of Fabry disease seen in men; although compared with hemizygous males, signs and symptoms of Fabry disease in women typically emerge at an older age and with less severity.

Fabry Disease: Epidemiology
The Fabry Disease epidemiology division provides insights into the historical and current patient pool and the forecasted trend for every seven major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the report also provides the diagnosed patient pool and their trends, along with assumptions undertaken.

Key Findings
The disease epidemiology covered in the report provides historical and forecasted Fabry Disease epidemiology segmented as the prevalent cases of Fabry Disease, Gender-specific cases of Fabry Disease, Phenotype-specific cases of Fabry Disease, and Age-specific cases of Fabry Disease. The report includes the prevalent scenario of Fabry Disease in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2019 to 2032.

Country-wise Fabry Disease Epidemiology
The epidemiology segment also provides the Fabry Disease epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
The total prevalent population of Fabry Disease in the 7MM countries was estimated to be more than 13,000 cases in 2020.
As per the estimates, the United States had the highest prevalent population of Fabry Disease in 2022. Among the EU5 countries, the Germany had the highest prevalent population of Fabry Disease with approximately 1,150 cases, followed by the UK in 2020. On the other hand, Spain had the lowest, nearly 650 cases in 2020.

Scope of the Report
• Fabry Disease report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns.
• Fabry Disease Epidemiology Report and Model provide an overview of the risk factors and global trends of Fabry Disease in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
• The report provides insight into the historical and forecasted patient pool of Fabry Disease in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan.
• The report helps recognize the growth opportunities in the 7MM concerning the patient population.
• The report assesses the disease risk and burden and highlights the unmet needs of Fabry Disease.
• The report provides the segmentation of the Fabry Disease epidemiology by prevalent cases of Fabry Disease in the 7MM.
• The report provides the segmentation of the Fabry Disease epidemiology by gender-specific cases of Fabry Disease in the 7MM.
• The report provides the segmentation of the Fabry Disease epidemiology by phenotype-specific cases of Fabry Disease in the 7MM.
• The report provides the Fabry Disease epidemiology segmentation by age-specific Fabry Disease cases in the 7MM.

Report Highlights

• 11-year Forecast of Fabry Disease epidemiology
• 7MM Coverage
• Prevalent Cases of Fabry Disease
• Gender-specific Cases of Fabry Disease
• Phenotype-specific Cases of Fabry Disease
• Age-specific Cases of Fabry Disease

KOL Views
We interview KOLs and obtain SME’s opinions through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatments by identifying the overall scenario of the indications.

Key Questions Answered
• What major factors will drive the change in the patient population in Fabry Disease during the forecast period (2019–2032)?
• What are the key findings of the Fabry Disease epidemiology across 7MM, and which country will have the highest number of patients during the forecast period (2019–2032)?
• What would be the total number of patients with Fabry Disease across the 7MM during the forecast period (2019–2032)?
• Among the EU5 countries, which country will have the highest number of patients during the forecast period (2019–2032)?
• At what CAGR is the patient population expected to grow in the 7MM forecast period (2019–2032)?
• What are the disease risk, burdens, and unmet needs of Fabry Disease?
• What are the currently available treatments for Fabry Disease?

Reasons to buy
Fabry Disease Epidemiology report will allow the user to:
• Develop business strategies by understanding the trends shaping and driving the global Fabry Disease market.
• Quantify patient populations in the global Fabry Disease market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Fabry Disease therapeutics in each market covered.
• Understand the magnitude of the Fabry Disease population by its prevalent cases.
• Understand the magnitude of the Fabry Disease population by its gender-specific cases.
• Understand the magnitude of the Fabry Disease population by its phenotype-specific cases.
• Understand the magnitude of the Fabry Disease population by its age-specific cases.
• The Fabry Disease epidemiology report and model were written and developed by Masters and PhD level epidemiologists.
• The Fabry Disease Epidemiology Model developed is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports the data presented in the report and showcases disease trends over an 11-year forecast period using reputable sources.

Key Assessments
• Patient Segmentation
• Disease Risk and Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population

Geographies Covered
• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2019–2032

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected]linker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

ref:plp2022

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on